Overview: Erythropoietin (EPO) TestIntroduction: The Erythropoietin (EPO) Test measures erythropoietin to diagnose anemia or kidney disorders, causing fatigue or shortness of breath. Following 2023 ASH guidelines, it uses an immunoassay for high sensitivity, aiding in hematological screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in biochemistry for patients with suspected anemia or kidney dysfunction.
Other Names: EPO Assay, Hematopoiesis Hormone Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: EPO testing began in the 1980s with anemia research. Immunoassays emerged in the 1990s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Diagnoses anemia or kidney disorders, guides treatment, and monitors EPO levels in patients with fatigue or shortness of breath.
Test Parameters: 1. Erythropoietin
Pretest Condition: Fasting for 10-12 hours required to stabilize hormone levels. Collect serum or plasma in the morning. Report symptoms like fatigue or shortness of breath, and list medications.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, shortness of breath, or history of anemia/kidney disorders. Include current medications, especially EPO therapy or iron supplements.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for anemia or kidney therapy.
Procedural Considerations: Uses an immunoassay to measure EPO levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting, inflammation, or medications can affect results. Hemolysis may degrade samples.
Clinical Significance: Abnormal EPO levels suggest anemia or kidney dysfunction, prompting treatment (e.g., EPO therapy). Normal levels may require further testing.
Specialist Consultation: Consult a hematologist or nephrologist for result interpretation.
Additional Supporting Tests: Complete blood count, iron studies, or kidney function tests to confirm anemia or kidney disorders.
Test Limitations: Results may be affected by inflammation or medications. Clinical correlation is required.
References: ASH Anemia Guidelines, 2023; Blood, Koury MJ, 2022.
